These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9001442)

  • 1. Biochemical alterations in guinea pig adrenal cortex following administration of PD 132301-2, an inhibitor of acyl-CoA:cholesterol acyltransferase.
    Wolfgang GH; MacDonald JR; Vernetti LA; Pegg DG; Robertson DG
    Life Sci; 1995 Feb; 56(13):1089-93. PubMed ID: 9001442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs.
    LaPensee CR; Mann JE; Rainey WE; Crudo V; Hunt SW; Hammer GD
    Endocrinology; 2016 May; 157(5):1775-88. PubMed ID: 26986192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-coenzyme A: cholesterol acyltransferase and cholesterol ester hydrolase in the outer and inner cortices of the guinea pig adrenal: effects of adrenocorticotropin and dexamethasone.
    Brody RI; Black VH
    Endocrinology; 1988 May; 122(5):1722-31. PubMed ID: 2834171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity.
    Trivedi BK; Purchase TS; Holmes A; Augelli-Szafran CE; Essenburg AD; Hamelehle KL; Stanfield RL; Bousley RF; Krause BR
    J Med Chem; 1994 May; 37(11):1652-9. PubMed ID: 8201599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACAT-selective and nonselective DGAT1 inhibition: adrenocortical effects--a cross-species comparison.
    Floettmann JE; Buckett LK; Turnbull AV; Smith T; Hallberg C; Birch A; Lees D; Jones HB
    Toxicol Pathol; 2013; 41(7):941-50. PubMed ID: 23427273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel acyl-CoA: cholesterol acyltransferase inhibitor: the synthesis, biological evaluation, and reduced adrenal toxicity of (4-phenylcoumarin)acetanilide derivatives with a carboxylic acid moiety.
    Ogino M; Nakada Y; Negoro N; Itokawa S; Nishimura S; Sanada T; Satomi T; Kita S; Kubo K; Marui S
    Chem Pharm Bull (Tokyo); 2011; 59(11):1369-75. PubMed ID: 22041073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional differences in cholesterol ester hydrolase and acyl-coenzyme-A/cholesterol acyltransferase between the outer and inner zones of the guinea pig adrenal cortex.
    Nishikawa T; Mikami K; Saito Y; Tamura Y; Yoshida S
    Endocrinology; 1988 Mar; 122(3):877-83. PubMed ID: 3342756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphogenesis of a zone-specific adrenocortical cytotoxicity in guinea pigs administered PD 132301-2, an inhibitor of acyl-CoA:cholesterol acyltransferase.
    Dominick MA; Bobrowski WA; MacDonald JR; Gough AW
    Toxicol Pathol; 1993; 21(1):54-62. PubMed ID: 8397438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of membrane environment on inhibition of acyl-CoA:cholesterol acyltransferase by a range of synthetic inhibitors.
    Harte RA; Yeaman SJ; Jackson B; Suckling KE
    Biochim Biophys Acta; 1995 Oct; 1258(3):241-50. PubMed ID: 7548193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture.
    Junquero D; Pilon A; Carilla-Durand E; Patoiseau JF; Tarayre JP; Torpier G; Staels B; Fruchart JC; Colpaert FC; Clavey V; Delhon A
    Biochem Pharmacol; 2001 Feb; 61(4):387-98. PubMed ID: 11226372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute toxicity of a novel inhibitor of acyl-CoA: cholesterol acyltransferase in beagle dogs.
    Dominick MA; McGuire EJ; Reindel JF; Bobrowski WF; Bocan TM; Gough AW
    Fundam Appl Toxicol; 1993 Feb; 20(2):217-24. PubMed ID: 8383621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
    Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
    Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR145237.
    Matsuo M; Hashimoto M; Suzuki J; Iwanami K; Tomoi M; Shimomura K
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):387-92. PubMed ID: 8887456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The participation of sterol carrier protein2 in cholesterol esterification in rat adrenal microsomes.
    Oeda T; Hirai A; Ban T; Tamura Y; Yoshida S
    Endocrinol Jpn; 1990 Apr; 37(2):285-92. PubMed ID: 2226346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the acyl-CoA: cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue.
    Kelley JL; Suenram CA; Rozek MM; Schaffer SA; Schwartz CJ
    Biochim Biophys Acta; 1988 May; 960(1):83-90. PubMed ID: 3358947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 2. Identification and structure-activity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N'-arylureas.
    Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
    J Med Chem; 1998 Jun; 41(13):2390-410. PubMed ID: 9632372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP depletion is associated with cytotoxicity of a novel lipid regulator in guinea pig adrenocortical cells.
    Vernetti LA; MacDonald JR; Wolfgang GH; Dominick MA; Pegg DG
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):30-8. PubMed ID: 8381566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.